AUTOIMMUNITY
Ed Friedlander, M.D., Pathologist
scalpel_blade@yahoo.com

Cyberfriends: The help you're looking for is probably here.

Welcome to Ed's Pathology Notes, placed here originally for the convenience of medical students at my school. You need to check the accuracy of any information, from any source, against other credible sources. I cannot diagnose or treat over the web, I cannot comment on the health care you have already received, and these notes cannot substitute for your own doctor's care. I am good at helping people find resources and answers. If you need me, send me an E-mail at scalpel_blade@yahoo.com Your confidentiality is completely respected.

DoctorGeorge.com is a larger, full-time service. There is also a fee site at myphysicians.com, and another at www.afraidtoask.com.

Translate this page automatically

Freely have you received, give freely With one of four large boxes of "Pathguy" replies.

I'm still doing my best to answer everybody. Sometimes I get backlogged, sometimes my E-mail crashes, and sometimes my literature search software crashes. If you've not heard from me in a week, post me again. I send my most challenging questions to the medical student pathology interest group, minus the name, but with your E-mail where you can receive a reply.

Numbers in {curly braces} are from the magnificent Slice of Life videodisk. No medical student should be without access to this wonderful resource. Someday you may be able to access these pictures directly from this page.

I am presently adding clickable links to images in these notes. Let me know about good online sources in addition to these:

Freely have you received, freely give. -- Matthew 10:8. My site receiver(an enormous amount of traffic, and I'm handling about 200 requests for information weekly, all as a public service.

Pathology's modern founder, Rudolf Virchow M.D., left a legacy of realism and social conscience for the discipline. I am a mainstream Christian, a man of science, and a proponent of common sense and common kindness. I am an outspoken enemy of all the make-believe and bunk that interfere with peoples' health, reasonable freedom, and happiness. I talk and write straight, and without apology.

Throughout these notes, I am speaking only for myself, and not for any employer, organization, or associate.

Special thanks to my friend and colleague, Charles Wheeler M.D., pathologist and former Kansas City mayor. Thanks also to the real Patch Adams M.D., who wrote me encouragement when we were both beginning our unusual medical careers.

If you're a private individual who's enjoyed this site, and want to say, "Thank you, Ed!", then what I'd like best is a contribution to the Episcopalian home for abandoned, neglected, and abused kids in Nevada:

I've spent time there and they are good. Write "Thanks Ed" on your check.

Help me help others

My home page
More of my notes
My medical students

Especially if you're looking for information on a disease with a name that you know, here are a couple of great places for you to go right now and use Medline, which will allow you to find every relevant current scientific publication. You owe it to yourself to learn to use this invaluable internet resource. Not only will you find some information immediately, but you'll have references to journal articles that you can obtain by interlibrary loan, plus the names of the world's foremost experts and their institutions.

Alternative (complementary) medicine has made real progress since my generally-unfavorable 1983 review linked below. If you are interested in complementary medicine, then I would urge you to visit my new Alternative Medicine page. If you are looking for something on complementary medicine, please go first to the American Association of Naturopathic Physicians. And for your enjoyment... here are some of my old pathology exams for medical school undergraduates.

I cannot examine every claim that my correspondents share with me. Sometimes the independent thinkers prove to be correct, and paradigms shift as a result. You also know that extraordinary claims require extraordinary evidence. When a discovery proves to square with the observable world, scientists make reputations by confirming it, and corporations are soon making profits from it. When a decades-old claim by a "persecuted genius" finds no acceptance from mainstream science, it probably failed some basic experimental tests designed to eliminate self-deception. If you ask me about something like this, I will simply invite you to do some tests yourself, perhaps as a high-school science project. Who knows? Perhaps it'll be you who makes the next great discovery!

Our world is full of people who have found peace, fulfillment, and friendship by suspending their own reasoning and simply accepting a single authority that seems wise and good. I've learned that they leave the movements when, and only when, they discover they have been maliciously deceived. In the meantime, nothing that I can say or do will convince such people that I am a decent human being. I no longer answer my crank mail.

This site is my hobby, and I presently have no sponsor.

This page was last updated February 6, 2006.

During the ten years my site has been online, it's proved to be one of the most popular of all internet sites for undergraduate physician and allied-health education. It is so well-known that I'm not worried about borrowers. I never refuse requests from colleagues for permission to adapt or duplicate it for their own courses... and many do. So, fellow-teachers, help yourselves. Don't sell it for a profit, don't use it for a bad purpose, and at some time in your course, mention me as author and KCUMB as my institution. Drop me a note about your successes. And special thanks to everyone who's helped and encouraged me, and especially the people at KCUMB for making it possible, and my teaching assistants over the years.

Whatever you're looking for on the web, I hope you find it, here or elsewhere. Health and friendship!

HONcode accreditation 
            seal. We comply with the HONcode standard for health trust worthy information:
verify here.

PicoSearch
  Help

More of Ed's Notes: Ed's Medical Terminology Page

Perspectives on Disease
Cell Injury and Death
Accumulations and Deposits
Inflammation
Fluids
Genes
What is Cancer?
Cancer: Causes and Effects
Immune Injury
Autoimmunity
Other Immune
HIV infections
The Anti-Immunization Activists
Infancy and Childhood
Aging
Infections
Nutrition
Environmental Lung Disease
Violence, Accidents, Poisoning
Heart
Vessels
Respiratory
Red Cells
White Cells
Coagulation
Oral Cavity
GI Tract
Liver
Pancreas (including Diabetes)
Kidney
Bladder
Men
Women
Breast
Pituitary
Thyroid
Adrenal and Thymus
Bones
Joints
Muscles
Skin
Nervous System
Eye
Ear
Autopsy
Lab Profiling
Blood Component Therapy
Serum Proteins
Renal Function Tests
Adrenal Testing
Arthritis Labs
Glucose Testing
Liver Testing
Porphyria
Urinalysis
Spinal Fluid
Lab Problem
Quackery
Alternative Medicine (current)
Alternative Medicine (1983)
Preventing "F"'s: For Teachers!
Medical Dictionary

Courtesy of CancerWEB

Learning Objectives

Describe some theoretical mechanisms of autoimmune disease. Give examples of known or suspected triggers for autoimmune disease.

List the common autoimmune diseases -- both those included in this lecture, and related disorders.

Give the predisposing factors, typical symptoms, signs, laboratory findings (especially autoantibodies), and pathologic anatomy for each of the following:

Give the distinguishing features for each of the following:

Recognize the following using the microscope:

Recognize lupus as today's "great imposter", and keep a high index of suspicion for all the common autoimmune diseases.

Autoimmunity
From Chile
In Spanish

Immune System
Mark W. Braun, M.D.
Photomicrographs

Immunopathology
Great pathology images
Indiana Med School

INTRODUCTION TO AUTOIMMUNE DISEASE

A3

familial hemochromatosis (gene is in this and some other alleles

B8 & DR3

autoimmune Addisonism
myasthenia gravis
Sjogren's

B27

ankylosing spondylitis
Reiter's syndrome
enteropathic arthropathy
autoimmune uveitis

B35

DeQuervain's

B38

psoriatic arthritis

B51

Beçet's

B47

21-hydroxylase deficiency (gene is in the allele)

Cw6

common psoriasis

DR2

Goodpasture's
multiple sclerosis

DR3

celiac sprue / dermatitis herpetiformis
lupoid hepatitis
lupus (weak)

DR3, DR4

autoimmune diabetes

DR4

pemphigus
rheumatoid arthritis

DR5

autoimmune pernicious anemia
Hashimoto's autoimmune thyroiditis

THE AUTOANTIBODIES (Am. J. Med. 100(2A): 16S, 1996)

RIM PATTERN Probably anti-dsDNA. Your patient probably has systemic lupus.

HOMOGENEOUS PATTERN Probably anti-histones. Your patient probably has drug-induced lupus.

SPECKLED PATTERN Could be anti-Sm and/or anti-Ro/SSA and/or anti-La/SSB and/or anti-U1RNP and/or any of several others. You'll certainly want to continue your workup!

CENTROMERE PATTERN An especially fine speckling with little background staining. This is anti-centromere, the marker for CREST / pulmonary hypertension.

NUCLEOLAR PATTERN anti-Th or anti-fibrillarin / anti-U3RNP or anti-U17RNP. Think of scleroderma, though most scleroderma patients don't show the nucleolar pattern.

anti-dsDNA Anti-double stranded DNA. A misnomer, of course. Your patient has systemic lupus. About half of lupus patients have these antibodies.

anti-ssDNA Anti-single stranded DNA. Think of drug-induced lupus.

anti-histone Think of drug-induced lupus.

anti-Sm Anti-Smith. Your patient has systemic lupus. About a third of lupus patients have these antibodies.

anti-Ro/SSA Lupus, Sjogren's, neonatal lupus, or some mix of these.

anti-La/SSB Lupus, Sjogren's, or some mix of these

anti-U1RNP Anti-ribonucleoprotein. When this is the main autoantibody, your patient has mixed connective tissue disease.

Anti-Scl70 Anti-topoisomerase. Your patient has the bad kind of scleroderma. A large minority of people with the bad kind of scleroderma have this autoantibody.

Anti-centromere Very sensitive and very specific for CREST, the limited scleroderma variant.

Anti-Jo Antibody against transfer-RNA synthetase. Your patient probably has polymyositis / dermatomyositis. About half of PMDM patients have this autoantibody.

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE, "the red wolf"; NIH review Ann. Int. Med. 123: 42, 1995; Med. Clin. N.A. 81: 113, 1997).

Lupus
From Chile
In Spanish

Lupus
Text and pictures
From "Big Robbins"

Pathology of Lupus
WebPath Tutorial

{08403} lupus immune complexes (green) trapped in the glomerulus
{28142} discoid lupus on the face (what features do you see?)

{08394} LE cell; Giemsa stained preparation
{29440} LE cells, Papanicolaou stain

        * In one old mouse model for lupus, the autoantibody is directed against a single phosphodiester linkage (which unfortunately for the mice is ubiquitous).

        Anti-Ro ("anti-SSA", an autoantibody against an RNA polymerase) crosses the placenta and causes heart block and discoid rash in newborns (probably by a type II immunologic injury). * It also binds to the epidermis, and probably causes some of the photosensitivity.

          * More than you want to know about Ro and La: Arth. Rheum. 42: 199, 1999.

        Antibodies against neurons are thought to cause the psychosis and convulsions often seen in lupus (Type II immunologic injury)

        Antibodies against blood cells are known to cause the hemolytic anemia, neutropenia, and thrombocytopenia often seen (together or separately) in lupus (Type II immunologic injury).

        Antigen-antibody complexes probably cause most of the arthritis and vasculitis (Type III immunologic injury).

        Lupus vasculitis
        The histopathology is nonspecific
        WebPath photo

          Because of the vasculitis (?), lupus patients have accelerated atherosclerosis (NEJM 349: 2399, 2003).

        Antibodies to one's own procoagulant activator complex (* Va + X + phospholipid) is the troublesome "lupus anticoagulant" (an antiphospholipid antibody that inactivates a freely-floating molecule). This causes paradoxical deep-vein thrombosis, thrombocytopenia, and abortion. See below.

        Antibodies against other clotting factors also can cause trouble.

      Lupus patients make many other weird antibodies. (You will learn how and when to test for these sometime.) For example, they tend to develop false-positive syphilis tests (* "biologic false positives", BFP's).

      Genetic factors:

        * Lupus patients often have HLA-DR2, DR3, A1, and/or B8. The DR2 locus is often linked to a null allele for C4 (there's a mouse model for this now too).

        Lupus runs in families, and there's been a great deal of work in the past ten years, mostly people trying to figure out what alleles for what immune molecules ("candidate genes") run with the disease. There's been a lot of data, but no unifying ideas.

        Monozygous twins are 25% concordant for lupus, dizygous only 2% (Arth. Rheum. 35: 311, 1992).

        Patients with hereditary C2, C4, * C1q (Arth. Rheum. 39: 663, 1996), * C1r, * C1s, * C5, * C7, or * C9 deficiencies get a lupus-like syndrome (Ann. Rheum. Dis. 46: 153, 1987).

      The search for a virus in lupus has been unrewarding. * The "myxovirus-like particles" ("tubular arrays") seen in endothelium are a non-specific alpha-interferon effect (Arthr. Rheum. 29: 501, 1986).

      Lupus kidney
      These are tubular arrays
      WebPath photo

    Blood vessels:

      Lupus vasculitis typically involves the small arteries and arterioles. Type III immune complex injury is usually implicated.

      When acute vasculitis is bad, plasma proteins that have gelled in the walls are called "fibrinoid". If the walls are dead, "fibrinoid necrosis" is said to be present.

      More chronic vasculitis leads to fibrosis and narrowing of vessels.

    Kidney: ("The kidney is never normal in ANA-positive systemic lupus.")

      The glomerulus traps antigens or pre-formed immune complexes as the strainer does in a sink. Several different glomerular syndromes can result.

Lupus glomerulonephritis
The dark pink is immune complexes
WebPath photo

Lupus glomerulonephritis
Lots of immune complexes
WebPath photo

Lupus glomerulonephritis
Lots of immune complexes
WebPath photo

      In addition, anti-tubular antibodies ("lupus interstitial nephritis") and vasculitis can impair kidney function.

    Skin:

      Patients must avoid sunlight. The famous "butterfly rash" results (at least in part) from sunlight on the malar area of the face.

Systemic lupus
Butterfly rash
KU Collection

Butterfly rash
WebPath photo

Butterfly rash
WebPath photo

Butterfly Rash
Patient photo
Brazilian Medical Students

{08388} butterfly rash
{12273} butterfly rash
{12274} butterfly rash
{25551} butterfly rash
{33208} lupus butterfly

      The "discoid rash" is also exacerbated by sun exposure.

        Involved areas are sharply demarcated ("discoid"), depigmented (the edges are likely to be hyperpigmented), hairless, scaly, and shiny. The microscopic picture shows:

        • areas of acanthosis and parakeratosis of the epidermis, with keratin plugging of follicles, alternating with areas of thinning and loss of adnexa
        • hydropic change of the basal cells, which may lead to necrosis
        • hyperemia and edema of the dermal papillae
        • a round cell infiltrate in the upper dermis, especially around the adnexa

{14316} discoid lupus
{08376} discoid rash of lupus, histology (nice local hydropic change in basal layer)
{11985} discoid lupus
{28868} discoid lupus
{28877} discoid lupus (good plugs)
{28880} discoid lupus (good atrophy / hyperkeratosis of epidermis)

      Discoid lupus
      WebPath photo

      Deposits of immunoglobulins and complement components ("fibrinoid") are found just below the basement membrane of both involved and uninvolved skin in the majority of lupus patients. These are detected by the "lupus band test" -- more on this when you see us again, or see Clin. Exp. Rheum. 17: 427, 1999.

        * The old claim that the lupus band test on non-sun-exposed skin being positive in systemic lupus and negative in discoid lupus is discredited.

      Hives, ulcers, blisters all result from immune injury.

        * Future dermatologists: Try topical tacrolimus (Rheumatology 43: 1383, 2004).

{08385} positive lupus band test (granules along basement membrane are immune complexes)
{33205} positive lupus band test, better example

Positive lupus band test
WebPath photo

Positive lupus band test
WebPath photo

      Mouth ulcers ("aphthae", little infarcts) are another annoying problem for many lupus patients.

    Joints:

      Arthritis (inflammation of joint tissues) is common in lupus. It resembles rheumatoid arthritis, though it is seldom mutilating.

        It is probably due to type III immune injury. The histology is acute and chronic synovitis.

    "Serositis":

      Pleural and pericardial inflammation creates pain and small fibrinous effusions. By autopsy time, all lupus patients have pleural scarring.

    Heart (Mayo Clin. Proc. 74: 275, 1999):

      The best-known and most typical change is "nonbacterial verrucous endocarditis" (verrucous means warty), also called "Libman-Sacks endocarditis".

        Many small vegetations occur on all parts of the mitral and tricuspid valves and chordae. They are made up of necrotic debris with acute and chronic inflammation; they may organize. Usually an incidental finding at autopsy, they sometimes cause trouble clinically.

        Despite old claims to the contrary, valves do in fact become mutilated in lupus, probably from fibrin organizing on their surfaces (NEJM 319: 861 & 877, 1988). * There is a strong correlation between Libman-Sacks and the presence of antiphospholipid antibody (Am. J. Med. 89: 411, 1990).

{06962} Libman-Sacks endocarditis in lupus

      Coronary vasculitis occasionally causes sudden death in lupus patients. In addition, these patients have accelerated coronary artery atherosclerosis for some reason, independent of the Framingham risk factors.

        * Current work looks at the presence of apoptotic endothelial cells as a marker for coronary disease and abnormal vascular tone, and an explanation for the vascular lesions generally. Stay tuned. Blood 103: 3677, 2004.

      "Neonatal lupus" is due to maternal anti-Ro(SSA) (* rarely anti-La/SSB or anti-U1-nRNP -- NEJM 316: 1135, 1987). These children have a rash and a serious heart block (anti-Ro attacks their AV node tissue). Anti-Ro is blamed for some loss of pregnancies, though evidence is conflicting (Br. J. Rheum. 37: 740, 1998). (Q. J. Med. 66: 125, 1988).

      * Lupus myocarditis is thankfully rarely apparent clinically, but today's high-powered cardiac investigations are picking up some subclinical cases (Am. J. Med. 113: 419, 2002).

    Blood:

      Patients with lupus have increased total serum gamma globulins ("polyclonal gammopathy"; a lab test result).

      Patients with "lupus anticoagulant" tend to have paradoxical thrombosis rather than hemorrhage. More about this soon.

        * This autoantibody is also common in people who do not have lupus, and if it is the presenting problem, the vast majority of patients do not develop systemic lupus (Medicine 84: 225, 2005).

        This was a subject for intensive investigation in the late 1980's. Closely akin to -- but not identical with -- lupus anticoagulant are anticardiolipin antibodies that cause spontaneous abortion (thrombosis and infarction of the placenta, or more plausibly, improper implantation Proc. Nat. Acad. Sci. 90: 6464, 1993) & thrombosis and are present in many patients with lupus. Both are related to false-positive tests for syphilis.

      And lupus patients can develop a bleeding tendency due to antibodies against clotting factors (especially factor VIII), thrombocytopenia, and/or vasculitis.

      Or they can just get deep vein thrombosis, without the anticoagulant (Arch. Int. Med. 154: 164, 1994).

      * Fulminating lupus hemophagocytic syndrome: Ann. Int. Med. 114: 387, 1991.

    Lungs:

      Only a few patients get pulmonary lesions directly attributable to lupus (Chest 88: 265, 1985).

      * In severe pulmonary lupus, the alveolar walls undergo fibrosis, probably as the result of type III immune complex injury. In bad cases, the vasculitis causes bleeding into the alveoli (Am. J. Clin. Path. 85: 552, 1986).

    Brain:

      Fatigue is a major problem for most lupus patients, and is often the presenting complaint (Arch. Neurol. 46: 1121, 1989).

      Antibodies against neurons probably cause the psychosis and convulsions often seen in lupus.

      Brain infarcts (strokes) are a serious problem in many lupus victims.

        * In the past, lupus cerebral vasculitis (few inflammatory cells, much intimal proliferation) has been blamed for most infarcts (strokes) in these patients. It now appears that lupus anti-cardiolipin antibody is present in most lupus patients with strokes, and the problem may be thrombosis instead (Am. J. Med. 86: 391, 1989).

      NMR studies show evanescent inflammatory lesions and/or generalized atrophy (Arthr. Rheum. 31: 159, 1988; J. Rheumatol. 15: 601, 1988).

      Anti-ribosomal P protein antibodies in the blood and anti-neuronal antibodies in the spinal fluid have been closely linked to lupus psychosis (but not other CNS problems): Arth. Rheum. 41: 1819, 1998.

    You will learn a great deal about working up lupus in advanced courses and on your internal medicine rotations.

      Most lupus patients have anti-native (i.e., anti-double stranded) DNA, and this antibody is unusual except in lupus patents. These usually also react with some ribonucleoproteins, which may drive their production (J. Clin. Invest. 93: 443, 1994).

      The few that don't have anti-native DNA will usually have anti-Ro/SSA (not specific for lupus), or anti-Sm ("Smith" antigen, a nuclear RNP, specific for lupus, though present in only 30%).

        * Molecular biology of Smith, which has some distinctive epitopes: J. Immuno. 167: 562, 2001.

      Remember that many healthy people have low titers of anti-nuclear antibodies.

    Clinical course and treatment:

      Lupus still kills people. Ten percent of patients presenting with overt lupus are dead from it within five years. This is usually the result of kidney failure, iatrogenic immunosuppression (infections), bleeding, heart failure, or brain damage.

        After several years, the incidence of myocardial infarction becomes very high in these patients, probably because of steroid therapy (Am. J. Med. 83: 503, 1987). Iatrogenic disease in lupus patients: JAMA 263: 1812, 1990.

      You will learn about various low-tech (* Omega-3 fish oil) treatments and high-tech (total lymphoid radiation, pulsed cyclophosphamide, super-high-chemo and stem-cell rescue Lancet 356: 701, 2000; lots more) treatments for lupus on rotations.

      * Medical history buffs: Queen Anne and lupus. Br. Med. J. 304: 1365, 1992.

    Lupus variants:

      Subacute cutaneous lupus erythematosus: Anti-Ro, HLA-DR3, sparing of the kidneys (Med. Clin. N.A. 73: 1073, 1989). Subclassifying the histopathology for dermatopathologists: Arch. Derm. 130: 54, 1994.

      Chronic discoid lupus erythematosus (the usual form of "chronic cutaneous lupus") shows only the skin changes. It is limited to sun-exposed skin, and immunofluorescence of uninvolved skin is normal. Around 10% of these patients eventually get the systemic disease, but most remain ds-DNA-negative and otherwise healthy.

      Most drug-induced lupus erythematosus is precipitated by hydralazine, procainamide, isoniazid, penicillamine, or phenytoin (* Lovastatin lupus: Arch. Int. Med. 151: 1667, 1991).

        The patients have anti-nuclear antibodies just as in lupus. Anti-histone antibodies (* "homogeneous pattern") are very characteristic, and the ones that actually make a person sick are anti-H2A-H2B antiguanosine autoantibodies (NEJM 318: 1431 & 1460, 1988).

        The drug is of course acting as a hapten. The disease resolves when the drug is withdrawn.

          Most of these patients are "slow acetylators"; you'll learn about them in Pharm. * The linkage is with HLA-DR4.

      Incomplete lupus: patients with suggestive findings but who do not meet the criteria for SLE. Prognosis is good (Arch. Int. Med. 149: 2473, 1989).

      Canine lupus is an important cause of morbidity in pet dogs ("Millie Bush's disease).

SJOGREN'S SYNDROME (Mikulicz's disease, "autoimmune exocrinopathy", "autoimmune epithelitis", etc. Review Br. J. Rheum. 35: 204, 1996.

    A common, usually mild illness characterized by autoimmune damage to the salivary and lacrimal glands, plus arthritis.

      Sometimes the vulvar and other glands are affected, and occasionally the renal tubules are ruined.

    Most patients are middle-aged women. Sjogren's affects perhaps 2 million people in the US.

    The terminology is a little loose. This seems to be the common usage:

      * "Mikulicz's syndrome" is large salivary and lacrimal glands infiltrated with lymphocytes, from any cause (Sjogren's, sarcoid, leukemia, lymphoma, AIDS, GVH-disease). Any of these diseases can cause dryness, and so can many common drugs, notably antihistamines, antipsychotic drugs, and antidepressants.

      "Sicca syndrome" is unexplained dry eyes ("keratoconjunctivitis sicca") and dry mouth ("xerostomia") together.

      * "Mikulicz's disease" or "autoimmune exocrinopathy" (neither in common use now) describe "sicca syndrome" due to autoimmune destruction.

      "Primary Sjogren's syndrome" is autoimmune exocrinopathy by itself, or with mild arthritis. Biopsy of a minor salivary gland (usually from normal-appearing lower lip) is now required for research subjects.

      "Secondary Sjogren's syndrome" is diagnosed when there is associated autoimmune disease: "Sjogren's with lupus", "Sjogren's with scleroderma", "Sjogren's with polymyositis", or "Sjogren's with rheumatoid arthritis". Very common -- perhaps a majority of these patients have it: Ann. Rheum. Dis. 46: 286, 1987.

      * "The benign lymphoepithelial lesion" is an anatomic pathologist's description of the glandular enlargement due to Sjogren's; it may present as a mass.

{35591} Sjogren's histology, minor salivary gland, fibrosis and lymphocytes
{35594} Sjogren's histology
{35597} Sjogren's histology; note lots and lots of lymphocytes

Sjogren's
Histopathology
WebPath photo

    The autoantigens in Sjogren's (primary or secondary) seems to be alpha-fodrin, a cytoskeleton component found in the salivary, lacrimal, and bronchial glands and rearranged when they secrete rapidly (Am. J. Path. 155: 173, 1999; Arch. Derm. 135: 535, 1999, Science 276: 604, 1997) and the type 3 muscarinic acetylcholine receptor (makes sense; Arth. Rheum. 44: 2376, 2001).

      T-cells (mostly helpers; see Semin. Arthr. Rheumatol. 14: 77, 1984) infiltrate and destroy the glands.

        The lymphocytic infiltration is patchy but dense, B-cells enter and germinal follicles may appear, and the acini and (later) ducts eventually are wrecked.

      * The B-cells show abnormalities of their immunoglobulin genes that are characteristic of cancers rather than benign hyperplasias -- see NEJM 316: 1118, 1987.

        The most interesting recent finding is that the epithelial cells in these glands show abnormal expression of HLA-DR's on their epithelial cells (Hum. Path. 19: 932, 1988). Obviously something's really scrambled.

        * Also intriguing is the development of Sjogren's syndrome both in HTLV-I infection and in HTLV-I tax transgenic mice (Nature 341: 72, 1989); where Sjogren's is endemic, the prevalence of antibodies is very high (Lancet 344: 1116, 1994).

      Primary or secondary, most Sjogren's patients have autoantibodies of one sort or another.

        Almost all female Sjogren's patients have antibodies against two "cytoplasmic" antigens, anti-Ro/SSA and anti-La/SSB (Ann. Rheum. Dis. 45: 732, 1986; Arthr. Rheum 29: 1223, 1986).

        Anti-Ro/SSA is found in many autoimmune diseases (remember it is the cause of neonatal lupus). * It is especially seen with type III immune-injury vasculitis, which can be devastating (Arthr. Rheumatol. 28: 1251, 1985; Am. J. Clin. Path. 88: 26, 1987).

        Anti-La/SSB is more specific for Sjogren's. (* Anti-RANA, described in Big Robbins, isn't proving very useful.)

        * The histo-compatibility antigens HLA-B8, Dw3, and DRw52 are markers for Sjogren's (Am. J. Med. 80: 23, 1986).

    Manifestations

      In "sicca syndrome", patients eventually get damage to the eyes, nasal and oral mucosa from dryness. Cracker sign: "Would you like to eat a dry cracker right now?" "NO!!" Ask whether the patient keeps a glass of water at the bedside to sip at night. Do you see lipstick on her front teeth? The unpleasant, official "dryness test" (* "Schirmer's") involves hanging a strip of filter paper out of the lower conjunctival sac for fifteen minutes and watching it not wet beyond 1 cm or so. This sounds like it violates the Geneva convention.

      "Sjogren's is an abnormal proliferation of lymphocytes". Patients with diagnosed primary Sjogren's often develop B-cell malignant lymphomas (around 10% of primary Sjogren's patients eventually get lymphoma (J. Rheum 24: 2376 1998 & many others.) Oncogenes and chromosomal rearrangements in "benign Sjogren's": Arth. Rheum. 40: 318, 1998.

      * Up to 40% of patients have an interstitial nephritis, and this is occasionally a problem (severe distal renal tubular acidosis, potassium wasting; Ann. Int. Med. 110: 405, 1989).

      * Dr. Sjogren's observation that these patients often develop chronic shortness of breath has been confirmed -- patients get a lymphocytic bronchiolitis and eventually develop the same symptoms as old smokers. See Arthr. Rheum. 30: 249, 1987.

SCLERODERMA ("[Progressive] Systemic Sclerosis"): Lancet 347: 1453, 1996; still good.

    A family of mild-to-miserable, usually slowly-progressive diseases with excessive fibrosis throughout the body. The skin is always involved; death is due to damage to the kidneys, lungs, heart, or GI tract. About one person in 4000 has scleroderma (Mayo Clin. Proc. 60: 105, 1985).

      The diagnosis of scleroderma is made on physical exam. It has never been a biopsy or lab doctor's disease.

    The etiology and pathogenesis of scleroderma remain obscure.

      * You'll hear reports of fibroblasts from these patients making too much collagen in tissue cultures, various cytokines (notably the newly-discovered CTGF, "connective tissue growth factor") causing excess collagen proliferation in the skin, and downregulation of proteins that prevent overcollagenization (Am. J. Path. 163: 571, 2003). However, no clear picture of the pathogenesis of scleroderma has emerged.

      Autoimmunity appears to be a factor, as these patients often have autoantibodies. Human graft-vs.-host disease resembles scleroderma's skin, lung, and vascular lesions, and the best animal model uses B- and T-cells from one mouse strain to attack the tissues of another (Arth. Rheum. 50: 1319, 2004).

        Anti-nucleolar antibodies (* don't bother learning their names) are worth remembering as they give the "nucleolar" pattern on the old anti-nuclear antibody screening test.

{33248} anti-nuclear antibody preparation in scleroderma, with each of the thousand points of light a different nucleolus

        Anti-topoisomerase (* Scl-86, etc.) is a marker for severe, diffuse disease, especially with lung involvement; more about the antibody and what keeps it going Arth. Rheum. 36: 1580, 1993; the epitope recognized determines the severity Arth. Rheum. 36: 1406, 1993). The antigen Scl-70, mentioned in Big Robbins, is a breakdown product of anti-topoisomerase.

          * This topoisomerase is a DNA-modifying enzyme that seems to work particularly well at the collagen gene, causing cells to produce too much collagen (Lancet 2: 475, 1988). This idea is supported by the discovery that the skin-tight mouse, the genetic model for scleroderma, has high topoisomerase, and if you can get the mouse to make fewer antibodies, it doesn't get so sick (Cell Immuno 167: 135, 1996). More on the mouse: Am. J. Path. 165: 641, 2004.

        Apoptosis of endothelium is seen early in the disease. * Claims in the mid-1990's that anti-endothelial antibodies mediated much of the damage in scleroderma have failed to find confirmation. More likely, the deadly onionskinning results from a complex interplay of molecules. Watch for abnormal fibrous responses to endothelial damage: J. Imm. 174: 5740, 2005.

        Anti-centromere antibody in high titer more or less defines the milder CREST syndrome, a scleroderma variant (see below; Br. J. Derm. 113: 381, 1985; Am. J. Med. 77: 812, 1984).

        * Anti-Th/To antibodies correlate with a milder, perhaps distinct, disease similar to CREST but with less gastrointestinal involvement (Arth. Rheum. 41: 74, 1998). Stay tuned.

        * Anti-fibrillarin antibodies correlate a severe, probably distinct scleroderma variant (Arth. Rheum. 39: 1151, 1996; J. Imm. 163: 1066, 1999).

        * Antibodies against RNA polymerases I and III (distinct from Ro and La) seem to define a separate scleroderma variant that is especially rough on the kidneys. (Br. J. Rheum. 37: 15, 1998). Antibodies against RNA polymerase II tend to occur with anti-topoisomerase I (Chest 114: 801, 1998). Stay tuned.

        * Fetal cells are found in the skin lesions of about half of women with scleroderma, raising the possibility that it's graft-vs.-host disease NEJM 338(17):1186, 1998. This is holding up: Rheumatology 43: 965, 2004. Watch for more on "microchimerism"; no one knows how common it is even in healthy mothers.

      In addition, there are vessel abnormalities.

        A vasculitis and monocytic infiltrate precedes the fibrosis as it progresses.

        Small vessels in many parts of the body show intimal proliferation. The histology is concentric fibrosis "onionskinning", but involving the intima this time) and/or myxoid proliferation.

{08466} onion-skinning of intima of small artery in scleroderma
{08469} intimal proliferation in scleroderma (elastic stain, kidney)
{24854} intimal proliferation in scleroderma demonstrated with PAS stain
{33259} intimal proliferation in small artery of the scleroderma kidney; the tubules are atrophic because of the longstanding lack of blood flow
{17124} kidney vascular changes in scleroderma

Scleroderma
From Chile
In Spanish

Scleroderma
Note the sclerodactyly and facial changes
WebPath photo

Scleroderma
(Riboflavin? C'mon.)
WebPath photo

Scleroderma
Intimal onionskinning
WebPath photo

Scleroderma Kidney
AJKD
Great pictures

        A clinician can detect scleroderma by observing that only a few large capillaries remain in the nail folds. ("How to": Arch. Derm. 139: 1027, 2003).

    Skin and cutaneous vessels (Med. Clin. N.A. 73: 1167, 1989):

      Visible skin changes are preceded in almost all cases by Raynaud's phenomenon (fingers blanching on exposure to cold; the color sequence is white-blue-red), and then by swelling. (Gangrene of the fingertips is the result of severe Raynaud's.)

      The skin eventually becomes tight and firm. This usually begins on the fingers ("sclerodactyly", "acrosclerosis") and hands.

        The dermis becomes increasingly collagenized, the epidermis thins and loses its adnexa ("atrophy"), and it may progress to immobility.

{14335} scleroderma, hands (notice calcium in knuckles)
{14336} scleroderma, finger (notice that the thin epidermis makes the skin shiny, and that the vessels are bunched at the nail root)
{25460} scleroderma, acrosclerosis
{24626} scleroderma, hands
{24917} scleroderma, histology of skin
{08460} scleroderma, histology of skin

Scleroderma
Skin changes
WebPath photo

Scleroderma
Skin changes
WebPath photo

        The altered dermis may calcify (feel for this in the finger pads). The calcium binds to gamma carboxyglutamic acid residues, so one can treat it with a low dose of coumarin.

        Onionskinning of the intima of the digital vessels is present, and probably explains the Raynaud's.

      The skin disease may never get farther than the hands, or may cause microstomia, bedsores, etc.

    Alimentary tract:

    Musculoskeletal system:

      There is a mild chronic synovitis, and about 15% of patients get some chronic myositis with elevated creatine kinase levels, and collagenization and weakness in proximal extremities.

    Kidneys:

      The classic lesion in the kidneys is intimal proliferation ("onion-skinning") of the interlobular arteries in the kidneys.

      Intimal onionskinning in the kidney is also typical of "malignant high blood pressure", where it is accompanied by necrosis and thrombosis of the arteries. One third of patients with scleroderma get high blood pressure due to the kidney changes, and one third of these get frank "malignant high blood pressure" ("scleroderma hypertensive crisis"). Great pictures: Am. J. Kid. Dis. 14: 236, 1989.

    Lungs:

      Scleroderma patients usually get a diffuse interstitial-alveolar fibrosis. This limits the ability to breathe ("restrictive lung disease") and to get oxygen into the bloodstream ("alveolar-capillary block", "diffusion barrier").

        A few scleroderma patients have severe pulmonary hypertension, with intimal onionskinning of the pulmonary arteries. This is more common in the CREST syndrome, where perhaps 10% are affected.

{33274} scleroderma lung; trichrome stain shows collagen/scar blue

      * Scleroderma patients often die during cold weather from chest colds.

    * Other organs:

      In unusual cases of scleroderma, there are cardiac arrhythmias, cardiomyopathy, polyneuropathy.

    Scleroderma variants:

      CREST syndrome ("limited cutaneous scleroderma") -- a milder variant of scleroderma, distinguished by the presence of anti-centromere antibody.

        Calcinosis, Raynaud's phenomenon, Esophageal dysfunction, Sclerodactyly, and Telangiectasias (groups of dilated vessels in the skin)

        Pulmonary hypertension and primary biliary cirrhosis (J. Derm. 26: 18, 1999) are common in CREST. The kidneys are usually spared.

        * For some reason, these people are also prone to bad periodontal disease.

      Morphea is "a form of scleroderma" confined to one area of the skin (Med. Clin. N.A. 73: 1143, 1989). Remember Lyme disease as one known cause of morphea (surprise!) Classic morphea does not turn into scleroderma and does not require any lab work beyond (probably) a Lyme check.

        * Future pathologists: The localized scleroderma variants feature inflammation and fibrosis of the papillary dermis; this is spared in regular scleroderma.

{12187} morphea
{14333} morphea
{15358} morphea

Morphea (localized scleroderma)
Prize photograph
Institute of Medical Illustrators

      Localized linear scleroderma ("sabre-cut scleroderma") is rare and follows a dermatome (Ann. Int. Med. 104: 849, 1986) and may involve the underlying muscle. It's the common form of morphea/scleroderma in children.

      Eosinophilic fasciitis is yet another systemic variant of scleroderma (Med. Clin. N.A. 73: 1157, 1989). One model for this was the L-tryptophan fiasco (NEJM 322: 874, 1990).

      * Scleroderma-like changes developed on the hands of vinyl chloride workers, and some cases have been linked to industrial solvent exposures (J. Occup. Med. 29: 493, 1987) and the Spanish toxic oil fiasco (an industrial lubricant loaded with fatty-acid anilides was sold door-to-door by crooks as olive oil). If augmentation mammoplasty is an additional cause, it is vanishingly rare (Ann. Int. Med. 111: 377, 1989; the article that sparked all the lawsuits).

    There is at present no highly-effective treatment for scleroderma. Penicillamine is often administered, which makes sense because it inhibits collagen synthesis. Gamma interferon is the most promising experimental therapy (Am. J. Med. 87: 273, 1989). Around 50% of scleroderma patients are alive five years after diagnosis (Arthr. Rheum. 34: 403, 1991); maybe half the time, the disease gets somewhat better by itself (Arth. Rheum. 44: 2828, 2001).

      * Halofuginone is a proposed drug for scleroderma; it prevents laying-down of the very-dense collagen, but not of normal collagen: J. Inv. Derm. 106: 84, 1996.

      Serendipity: Patients given Iloprost for their Raynaud's report that this greatly helps the skin tightening; perhaps this modulates the CTFG effect (J. Clin. Invest. 108: 241, 2001)

    * Medical history buffs: The most picturesque (and horrifying) Raynaud's syndrome is ergotism (intoxication with Claviceps purpura fungus from wet rye. Lysergic acid causes LSD-related psychosis as well as gangrene of the extremities and "St. Anthony's flame" neuropathy. Mass outbreaks are memorable and have occurred even in the mid-20th century.

POLYMYOSITIS (including "DERMATOMYOSITIS"; "DM-PM"; Lancet 355: 53, 2000);

    Polymyositis is an inflammatory disease that damages skeletal muscle. Today, along with dermatomyositis and some uncommon similar syndromes, there's a tendency to call it "idopathic inflammatory myositis".

      Groups of muscle cells degenerate, and there is a chronic inflammatory infiltrate in the muscle.

    Dermatomyositis is polymyositis plus skin involvement (* rarely, it occurs without polymyositis: amyopathic dermatomyositis Arch. Derm. 131: 1458, 1996).

      Various rashes occur, the characteristic ones being a lupus-like "butterfly rash", "heliotrope eyelids", and purple bumps on the knuckles (Gottron's sign). Others may mimic seborrhea.

{13120} Gottron's sign
{14342} heliotrope eyelids
{14338} Gottron's sign (easier to see on the left hand than on the right hand)
{14339} Gottron's sign
{14340} Gottron's sign
{15346} butterfly rash (closely resembles lupus)

Muscle biopsy in dermatomyositis
Text and photomicrographs
Dr. Warnock's Collection

    The etiology and pathogenesis of polymyositis-dermatomyositis are obscure. There is strong circumstantial evidence that autoimmunity is somehow involved, but you should ignore any elegant or complete descriptions of its pathogenesis.

      Polymyositis and dermatomyositis tend to occur with evidence of any of the other collagen-vascular diseases, or with rheumatic fever, sarcoidosis or cancer.

      Skeletal muscle ground up and injected with Freund's adjuvant is the basis for the induced animal models. In humans, some lymphocytes seem to be angry with skeletal muscle.

      Antisynthetase syndrome, a subcategory of polymyositis, features antibodies against several of t-RNA synthetases (J. Immunol. 144: 1737, 1990; Clin. Exp. Rheumatol. 8: 259, 1990). Anti-Jo-1 (anti-histidyl-tRNA synthetase) was the first of these antibodies, which are markers for polymyositis (anti-Jo-1 is very specific: Arth. Rheum. 39: 292, 1996) and also pulmonary fibrosis.

      * Suspected triggers include toxoplasmosis, parvoviruses, immunizations, "stress". The drug D-penicillamine (useful for rheumatoid arthritis and scleroderma) commonly causes DM-PM. * Simian AIDS features DM-PM in 50% of cases.

      * C2-deficient people get a polymyositis-like syndrome in addition to their lupus.... The idiopathic disease is often associated with HLA-DR3/B8. Attempts to isolate a virus have failed.

      * Dermatomyositis is a very common disease of collie and shelty puppies (Am. J. Path. 123: 465 & 480, 1986).

    Whatever the cause(s), the muscle changes on physical exam and biopsy are characteristic.

      Polymyositis affects the proximal muscles of the extremities most severely (weak hips and shoulders, weak neck flexors).

        It spares the extra-ocular muscles (making it easy to distinguish from myasthenia gravis).

        The muscles are at first sore, tender, swollen (edematous), and weak. (Patients may complain of "fatigue" instead).

      Perivascular and endomysial inflammation, and muscle cell necrosis, are usually present on biopsy but may be subtle.

      The pathologist also looks for decreased muscle cell diameter at the edge of the bundles (perifascicular atrophy), which is basically diagnostic.

      * Guessing from the biopsy whether it's polymyositis or dermatomyositis isn't reliable. If you must...

        Polymyositis

        • more T-CTL killer cells among the muscle fibers

        Dermatomyositis

        • more vasculitis

        • immune complex deposits

        • single-fiber necrosis

        • fibrosis

        • really striking perifascicular atrophy

{05780} dermatomyositis, histology; note the lymphocytes in this particular case
{05789} dermatomyositis, late, trichrome stain; muscle cells (red) are largely replaced by scar tissue (blue)
{09039} polymyositis, histology in muscle; note lymphocytes
{14358} polymyositis, histology; good perifascicular atrophy
{29501} polymyositis; find a few examples each of muscle fibers undergoing necrosis, atrophy, and regeneration

    You will learn about the diagnosis of polymyositis-dermatomyositis in clinics.

      There are often increased circulating eosinophils, especially in dermatomyositis.

      Serum muscle enzymes are greatly increased (check creatine kinase, * aldolase is measured less often)

      * Electromyography and muscle biopsy are also used.

      When you suspect dermatomyositis, rule out cancer, especially in older patients, especially of the ovary. In a large minority of cases, the disease is the first sign of an internal malignancy (Ann. Int. Med. 134: 1087, 2001; NEJM 326: 363, 1992).

    Polymyositis and dermatomyositis are miserable diseases, and are difficult to treat even today (Rheum. 44: 83, 2005).

      The treatments (glucocorticoids, cytotoxic agents to suppress the immune response) do not work very well and are dangerous. (See Arthr. Rheumatol. 28: 590, 1985; J. Rheumatol. 12: 283, 1985).

    Inclusion body myositis is a mild disease, usually involving older men's grip muscles. Despite "Big Robbins", it is NOT an immune disease. More about it soon.

MIXED CONNECTIVE TISSUE DISEASE (MCTD, "anti-U1-RNP disease")

    A mixed picture with features of lupus, polymyositis, and scleroderma. Patients have severe Raynaud's phenomenon, swollen fingers, mild myositis, and severe joint pain. The rest of the "mix" is more variable.

    The kidneys are spared, and response to steroids is good.

    High titers of antibodies against ribonucleoprotein (U1-RNP, one of the "speckled pattern" antibodies) are characteristic. Many rheumatologists challenge the status of MCTD and/or CREST as distinct diseases.

    Regardless, when U1RNP titers are high, the patient will likely have arthritis / myositis (Br. J. Rheum. 37: 39, 1998).

MCTD
Weird bowel lesion
Pittsburgh Pathology Cases

MCTD
Pittsburgh Pathology Cases

Mixed Connective Tissue Disease
Pittsburgh Illustrated Case

Anti-nuclear antibodies
Homogeneous pattern
WebPath photo

Anti-nuclear antibodies
Homogeneous pattern
WebPath photo

Anti-nuclear antibodies
Peripheral pattern
WebPath photo

Anti-nuclear antibodies
Speckled pattern
WebPath photo

Anti-nuclear antibodies
Nucleolar pattern
WebPath photo

Anti-nuclear antibodies
Nucleolar pattern
WebPath photo

* FIBROMYALGIA SYNDROME ("allodynia", "fibrositis", "rheumatic pain modulation disorder"; "muscular rheumatism", not an autoimmune disease Scand. J. Rheum. S94: 1-70, 1992 (huge); Br. Med. J. 310: 386, 1995; Am. Fam. Phys. 53: 1698, 1996; Postgrad. Med. 100(1): 153, July 1996; Am. J. Med. Sci. June 1998.

    Fibrositis is the most common diagnosis made by consulting rheumatologists today. This is an extremely common, distinct disease without any known anatomic or laboratory correlates. (Just like today's oh-so-organic migraine was in the pre-1990's era, remember? It is a mysterious pain syndrome with morning stiffness, deep tenderness at predictable locations ("trigger points" -- to learn where and how to poke, see Arthr. Rheum. 31: 182, 1988). Patients are often disabled. There are EEG abnormalities in deep sleep, and probably some kind of disturbance in brain serotonin metabolism. By now, it's clear that there is a central problem with pain modulation ("nociception") in these patients: Arth. Rheum. 36: 642, 1993; Arth. Rheum. 40: 98, 1997.

    Typical victims are young, effective women who dislike alcohol and Valium, and complain of nonrestorative sleep. Treating fibrositis is complex; aerobic exercise is important (swimming, being non-impact, is often helpful), and certain drugs seem to help (try cyclobenzoprine 10 mg q HS, helps a large minority of patients. or nowadays the newer antidepressants). Acupuncture at the trigger points has been reported as useful, as is injection of anesthetics. Acupuncture gets a "definite maybe" from the Maryland Complementary Medicine Program: J. Fam. Pract. 48: 213, 1999. There may be as many as 6 million patients with this illness in the U.S. I remember these patients being ridiculed (in the 1970's) as "total body pain" cases -- malingerers or neurotics. (Presently the "personality problems" of these patients are attributed to chronic pain.) Fibromyalgia syndrome is not presently considered to be an autoimmune disease. (This pathologist questions the experience of clinicians who have published photos of "positive lupus band tests" from these patients -- they look like classic negative studies. See RDCNA above.) Not everyone believes in fibromyalgia: Br. Med. J. 303: 216, 1991 (I couldn't follow this guy's logic). The 1992 Copenhagen Conference declared this to be a real entity (Lancet 340: 1103, 1992) and attempts a better definition.

    Get out the tricyclics (Arch. Int. Med. 156: 1047, 1996; Arth. Rheum. 39: 1852, 1996; J. Fam. Pract. 44: 128, 1997). In 1987, I predicted the selective serotonin uptake inhibitors would be successful in treating fibromyalgia, and this has now been nicely confirmed. Guifenesin, a current "pop" remedy, has a devoted following among self-help groups, and the drug seems to have some poorly-understood muscle-relaxant and analgesic properties (JABFP 17: 240, 2004; some obscure journals). Stay tuned.

* Lab workups for all the rheumatic diseases: Am. J. Med. 100(2S): 16-S, 1996.

* Reminder: You will study osteoarthritis ("wear and tear arthritis"), rheumatoid arthritis, the enthesopathies, and rheumatic fever later in the course. Another important cause of multi-joint arthritis is iron overload -- fairly common, and very preventable.

Visitors to www.pathguy.com
reset Jan. 30, 2005:

Ed at homeDrop by and meet Ed

Ed says, "This world would be a sorry place if people like me who call ourselves Christians didn't try to act as good as other good people ." Prayer Request

Teaching Pathology

Pathological Chess


Taser Video
83.4 MB
7:26 min